RXi Pharmaceuticals Corporation (NASDAQ:RXII)

CAPS Rating: 2 out of 5

Recs

0
Player Avatar pchop123 (78.61) Submitted: 1/29/2013 3:46:59 PM : Outperform Start Price: $1.75 RXII Score: +6.01

Cancer drugs that ultimately should show a profit

Featured Broker Partners


Advertisement